Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Free-living marine nematodes from San Antonio Bay (Río Negro, Argentina).

Villares G, Lo Russo V, Pastor de Ward C, Milano V, Miyashiro L, Mazzanti R.

Zookeys. 2016 Mar 28;(574):43-55. doi: 10.3897/zookeys.574.7222. eCollection 2016.

2.

Hepatocellular carcinoma: Where are we?

Mazzanti R, Arena U, Tassi R.

World J Exp Med. 2016 Feb 20;6(1):21-36. doi: 10.5493/wjem.v6.i1.21. eCollection 2016 Feb 20. Review.

3.

Free-living marine nematodes from San Julián Bay (Santa Cruz, Argentina).

Pastor de Ward C, Lo Russo V, Villares G, Milano V, Miyashiro L, Mazzanti R.

Zookeys. 2015 Mar 24;(489):133-44. doi: 10.3897/zookeys.489.7311. eCollection 2015.

4.

Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane.

Fantappiè O, Sassoli C, Tani A, Nosi D, Marchetti S, Formigli L, Mazzanti R.

J Cell Mol Med. 2015 Jun;19(6):1410-7. doi: 10.1111/jcmm.12528. Epub 2015 Feb 18.

5.

Hyperlipidemia and hypothyroidism among metastatic renal cell carcinoma patients taking sunitinib malate. Related or unrelated adverse events?

Tassi R, Baldazzi V, Lapini A, Carini M, Mazzanti R.

Clin Genitourin Cancer. 2015 Apr;13(2):e101-5. doi: 10.1016/j.clgc.2014.08.009. Epub 2014 Sep 22.

PMID:
25450040
6.

Delivery of doxorubicin across the blood-brain barrier by ondansetron pretreatment: a study in vitro and in vivo.

Sardi I, Fantappiè O, la Marca G, Giovannini MG, Iorio AL, da Ros M, Malvagia S, Cardellicchio S, Giunti L, de Martino M, Mazzanti R.

Cancer Lett. 2014 Oct 28;353(2):242-7. doi: 10.1016/j.canlet.2014.07.018. Epub 2014 Jul 29.

PMID:
25079687
7.

"Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183".

Marchetti S, Pluim D, Beijnen JH, Mazzanti R, van Tellingen O, Schellens JH.

Invest New Drugs. 2014 Dec;32(6):1083-95. doi: 10.1007/s10637-014-0143-0. Epub 2014 Jul 31.

PMID:
25078948
8.

A Tenebrionid beetle's dataset (Coleoptera, Tenebrionidae) from Peninsula Valdés (Chubut, Argentina).

Cheli GH, Flores GE, Román NM, Podestá D, Mazzanti R, Miyashiro L.

Zookeys. 2013 Dec 18;(364):93-108. doi: 10.3897/zookeys.364.4761. eCollection 2013 Dec 18.

9.

Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.

Bracarda S, Gernone A, Gasparro D, Marchetti P, Ronzoni M, Bortolus R, Fratino L, Basso U, Mazzanti R, Messina C, Tucci M, Boccardo F, Cartenì G, Pinto C, Fornarini G, Mattioli R, Procopio G, Chiuri V, Scotto T, Dondi D, Di Lorenzo G.

Future Oncol. 2014 May;10(6):975-83. doi: 10.2217/fon.13.256. Epub 2013 Dec 3.

10.

Abcc4 together with abcb1 and abcg2 form a robust cooperative drug efflux system that restricts the brain entry of camptothecin analogues.

Lin F, Marchetti S, Pluim D, Iusuf D, Mazzanti R, Schellens JH, Beijnen JH, van Tellingen O.

Clin Cancer Res. 2013 Apr 15;19(8):2084-95. doi: 10.1158/1078-0432.CCR-12-3105. Epub 2013 Mar 5.

11.

Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA.

Marchetti S, Pluim D, van Eijndhoven M, van Tellingen O, Mazzanti R, Beijnen JH, Schellens JH.

Invest New Drugs. 2013 Oct;31(5):1125-35. doi: 10.1007/s10637-013-9923-1. Epub 2013 Jan 13. Erratum in: Invest New Drugs. 2013 Jun;31(3):800.

PMID:
23315030
12.

Sunitinib-induced hyperparathyroidism: a possible mechanism to altered bone homeostasis.

Baldazzi V, Tassi R, Lapini A, Lunghi A, Garofoli E, Caruso S, Carini M, Mazzanti R.

Cancer. 2012 Jun 15;118(12):3165-72. doi: 10.1002/cncr.26435. Epub 2011 Sep 28.

13.

The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: a prospective single-center study.

Baldazzi V, Tassi R, Lapini A, Santomaggio C, Carini M, Mazzanti R.

Urol Oncol. 2012 Sep;30(5):704-10. doi: 10.1016/j.urolonc.2010.07.015. Epub 2010 Oct 2.

PMID:
20884255
14.

Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines.

Solazzo M, Fantappiè O, D'Amico M, Sassoli C, Tani A, Cipriani G, Bogani C, Formigli L, Mazzanti R.

Cancer Res. 2009 Sep 15;69(18):7235-42. doi: 10.1158/0008-5472.CAN-08-4315. Epub 2009 Aug 25.

15.

Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.

Mazzanti R, Platini F, Bottini C, Fantappiè O, Solazzo M, Tessitore L.

Biochem Pharmacol. 2009 Jul 1;78(1):21-32. doi: 10.1016/j.bcp.2009.03.013. Epub 2009 Mar 24.

PMID:
19447220
17.

Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice.

Marchetti S, de Vries NA, Buckle T, Bolijn MJ, van Eijndhoven MA, Beijnen JH, Mazzanti R, van Tellingen O, Schellens JH.

Mol Cancer Ther. 2008 Aug;7(8):2280-7. doi: 10.1158/1535-7163.MCT-07-2250.

18.

In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2.

Marchetti S, Oostendorp RL, Pluim D, van Eijndhoven M, van Tellingen O, Schinkel AH, Versace R, Beijnen JH, Mazzanti R, Schellens JH.

Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3307-13.

19.

Hepatocellular carcinoma: epidemiology and clinical aspects.

Mazzanti R, Gramantieri L, Bolondi L.

Mol Aspects Med. 2008 Feb-Apr;29(1-2):130-43. Epub 2007 Oct 24. Review.

PMID:
18061252
20.

Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.

Mazzanti R, Messerini L, Comin CE, Fedeli L, Ganne-Carrie N, Beaugrand M.

World J Gastroenterol. 2007 Oct 7;13(37):5009-14.

21.
22.

P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.

Fantappiè O, Solazzo M, Lasagna N, Platini F, Tessitore L, Mazzanti R.

Cancer Res. 2007 May 15;67(10):4915-23.

23.

The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate.

Oostendorp RL, Marchetti S, Beijnen JH, Mazzanti R, Schellens JH.

Cancer Chemother Pharmacol. 2007 May;59(6):855-60. Epub 2006 Dec 16.

PMID:
17180388
24.

P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines.

Solazzo M, Fantappiè O, Lasagna N, Sassoli C, Nosi D, Mazzanti R.

Exp Cell Res. 2006 Dec 10;312(20):4070-8. Epub 2006 Sep 16.

PMID:
17027968
25.

Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study.

Neri B, Vannozzi L, Fulignati C, Pantaleo P, Pantalone D, Paoletti C, Perfetto F, Turrini M, Mazzanti R.

Cancer Invest. 2006 Aug-Sep;24(5):474-8.

PMID:
16939954
26.

Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.

Bolondi L, Piscaglia F, Gatta A, Salerno F, Bernardi M, Ascione A, Ferraù O, Sacerdoti D, Visentin S, Trevisani F, Mazzanti R, Donati G, Arena U, Gentilini P; DOC (Decrease Of Complications in cirrhosis) Study Group.

Clin Gastroenterol Hepatol. 2006 Nov;4(11):1395-402. Epub 2006 Aug 22.

PMID:
16931172
27.

Coordination of nuclear- and mitochondrial-DNA encoded proteins in cancer and normal colon tissues.

Mazzanti R, Giulivi C.

Biochim Biophys Acta. 2006 May-Jun;1757(5-6):618-23. Epub 2006 Apr 20.

28.

Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.

Lasagna N, Fantappiè O, Solazzo M, Morbidelli L, Marchetti S, Cipriani G, Ziche M, Mazzanti R.

Cancer Res. 2006 Mar 1;66(5):2673-82.

29.

Gene therapy in cancer: the missing point.

Kanduc D, Geliebter J, Lucchese A, Mazzanti R, Mittelman A, Polimeno L, Ponzetto A, Santacroce R, Simone S, Sinigaglia E, Sinha AA, Tessitore L, Tiwari RK, Farber E.

J Exp Ther Oncol. 2005;5(2):151-8. Review.

PMID:
16471041
30.

Differential expression proteomics of human colon cancer.

Mazzanti R, Solazzo M, Fantappié O, Elfering S, Pantaleo P, Bechi P, Cianchi F, Ettl A, Giulivi C.

Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1329-38. Epub 2006 Jan 26.

31.

An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: a case report.

Fulignati C, Pantaleo P, Cipriani G, Turrini M, Nicastro R, Mazzanti R, Neri B.

World J Gastroenterol. 2005 May 28;11(20):3151-5.

32.

Treatment with inhibitors of angiogenesis in advanced hepatocellular carcinoma: a new tool in our hands or simply a hope?

Cipriani G, Mazzanti R.

Dig Liver Dis. 2005 Apr;37(4):230-1. Epub 2005 Jan 8. No abstract available.

PMID:
15788205
33.

Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.

Mazzanti R, Arena U, Pantaleo P, Antonuzzo L, Cipriani G, Neri B, Giordano C, Lanini F, Marchetti S, Gentilini P.

Can J Gastroenterol. 2004 Oct;18(10):611-8.

PMID:
15497001
34.

Vitamin E protects DNA from oxidative damage in human hepatocellular carcinoma cell lines.

Fantappiè O, Lodovici M, Fabrizio P, Marchettia S, Fabbroni V, Solazzo M, Lasagna N, Pantaleo P, Mazzanti R.

Free Radic Res. 2004 Jul;38(7):751-9.

PMID:
15453640
35.

The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids.

Vannacci A, Giannini L, Passani MB, Di Felice A, Pierpaoli S, Zagli G, Fantappiè O, Mazzanti R, Masini E, Mannaioni PF.

J Pharmacol Exp Ther. 2004 Oct;311(1):256-64. Epub 2004 Jun 8.

PMID:
15187170
36.

Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study.

Mazzanti R, Giallombardo AL, Mini E, Nobili S, Neri B, Arena U, Pantaleo P, Fabbroni V, Ghilardi M, Gattai R, Bandettini L.

Dig Liver Dis. 2004 Apr;36(4):278-85.

PMID:
15115341
37.

Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer.

Cianchi F, Cortesini C, Fantappiè O, Messerini L, Sardi I, Lasagna N, Perna F, Fabbroni V, Di Felice A, Perigli G, Mazzanti R, Masini E.

Clin Cancer Res. 2004 Apr 15;10(8):2694-704.

38.

Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart.

Masini E, Vannacci A, Marzocca C, Pierpaoli S, Giannini L, Fantappié O, Mazzanti R, Mannaioni PF.

Exp Biol Med (Maywood). 2003 May;228(5):546-9.

PMID:
12709584
39.

Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis.

Cianchi F, Cortesini C, Fantappiè O, Messerini L, Schiavone N, Vannacci A, Nistri S, Sardi I, Baroni G, Marzocca C, Perna F, Mazzanti R, Bechi P, Masini E.

Am J Pathol. 2003 Mar;162(3):793-801.

40.

Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study.

Daniele B, De Sio I, Izzo F, Capuano G, Andreana A, Mazzanti R, Aiello A, Vallone P, Fiore F, Gaeta GB, Perrone F, Pignata S, Gallo C; CLIP Investigators.

J Clin Gastroenterol. 2003 Jan;36(1):63-7.

PMID:
12488711
41.

Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial.

Perrone F, Gallo C, Daniele B, Gaeta GB, Izzo F, Capuano G, Adinolfi LE, Mazzanti R, Farinati F, Elba S, Piai G, Calandra M, Stanzione M, Mattera D, Aiello A, De Sio I, Castiglione F, Russo M, Persico M, Felder M, Manghisi OG, De Maio E, Di Maio M, Pignata S; Cancer of Liver Italian Program (CLIP) Investigators.

Curr Pharm Des. 2002;8(11):1013-9.

PMID:
11945148
42.

The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line.

Fantappiè O, Masini E, Sardi I, Raimondi L, Bani D, Solazzo M, Vannacci A, Mazzanti R.

Hepatology. 2002 Apr;35(4):843-52.

PMID:
11915030
43.

Haeme oxygenase-1 and cardiac anaphylaxis.

Ndisang JF, Wang R, Vannacci A, Marzocca C, Fantappiè O, Mazzanti R, Mannaioni PF, Masini E.

Br J Pharmacol. 2001 Dec;134(8):1689-96.

44.

Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer.

Cianchi F, Cortesini C, Bechi P, Fantappiè O, Messerini L, Vannacci A, Sardi I, Baroni G, Boddi V, Mazzanti R, Masini E.

Gastroenterology. 2001 Dec;121(6):1339-47.

PMID:
11729113
45.

Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up.

Neri B, Cini G, Andreoli F, Boffi B, Francesconi D, Mazzanti R, Medi F, Mercatelli A, Romano S, Siliani L, Tarquini R, Moretti R.

Br J Cancer. 2001 Apr 6;84(7):878-80.

46.

Reflux and pH: 'alkaline' components are not neutralized by gastric pH variations.

Bechi P, Cianchi F, Mazzanti R, Fantappiè O, Fiorillo C, Nassi P.

Dis Esophagus. 2000;13(1):51-5.

PMID:
11005332
47.

Gross pathologic types of hepatocellular carcinoma in Italy.

Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxì A, Chiaramonte M, Galante D, Manghisi OG, Mazzanti R, Medaglia C, Pilleri G, Rapaccini GL, Albanese M, Taliani G, Tosti ME, Villa E, Gasbarrini G.

Oncology. 1999 Apr;56(3):189-92.

PMID:
10202272
48.

Characteristics of hepatocellular carcinoma in Italy.

Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M, Galante D, Manghisi OG, Mazzanti R, Medaglia C, Pilleri G, Rapaccini GL, Simonetti RG, Taliani G, Tosti ME, Villa E, Gasbarrini G.

J Hepatol. 1998 Dec;29(6):944-52.

PMID:
9875641
49.

Respiratory mechanics in patients with tense cirrhotic ascites.

Duranti R, Laffi G, Misuri G, Riccardi D, Gorini M, Foschi M, Iandelli I, Mazzanti R, Mancini M, Scano G, Gentilini P.

Eur Respir J. 1997 Jul;10(7):1622-30.

50.

Long course and prognostic factors of virus-induced cirrhosis of the liver.

Gentilini P, Laffi G, La Villa G, Romanelli RG, Buzzelli G, Casini-Raggi V, Melani L, Mazzanti R, Riccardi D, Pinzani M, Zignego AL.

Am J Gastroenterol. 1997 Jan;92(1):66-72.

PMID:
8995940

Supplemental Content

Loading ...
Support Center